Opendata, web and dolomites

EMPAtHy SIGNED

Endothelial Cell Molecular and Metabolic Heterogeneity in Pulmonary Arterial Hypertension

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EMPAtHy project word cloud

Explore the words cloud of the EMPAtHy project. It provides you a very rough idea of what is the project "EMPAtHy" about.

ec    hemodynamic    foundation    thesis    animal    proof    ameliorative    career    metabolism    achievement    metabolically    overlooked    intrapulmonary    lung    1st    successful    subpopulations    pressure    freshly    yield    driving    pulmonary    never    validated    exception    heterogeneous    though    lab    insights    incurable    dramatic    frontline    profiles    isolated    experimental    innovative    hypertension    seq    science    arteries    expression    small    expertise    pathophysiology    environment    intense    ecs    international    clinically    basis    ph    promises    devastating    promotes    disciplinary    gene    academia    heterogeneity    background    therapy    forces    goals    phenotypically    disease    rewiring    competitive    survival    host    sequencing    remodeling    exposed    patients    output    combining    model    me    diverse    lay    endothelial    scientific    unbiased    rna    stimuli    phd    vascular    shown    cell    cells    phenotypic    arterial    metabolic    poor    microenvironments    single    vivo    curative    time    paradigm    replacement    scrna    pah   

Project "EMPAtHy" data sheet

The following table provides information about the project.

Coordinator
VIB VZW 

Organization address
address: RIJVISSCHESTRAAT 120
city: ZWIJNAARDE - GENT
postcode: 9052
website: www.vib.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 166˙320 €
 EC max contribution 166˙320 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIB VZW BE (ZWIJNAARDE - GENT) coordinator 166˙320.00

Map

 Project objective

BACKGROUND: Pulmonary arterial hypertension (PAH) is a devastating disease, characterized by a dramatic increase in pulmonary arterial pressure and an intense remodeling of small intrapulmonary arteries. With the exception of the lung replacement therapy, PAH remains an incurable disease with poor survival. Recent studies have shown that in PAH, rewiring of the metabolism of the lung endothelial cells (ECs) promotes vascular remodeling. However, these studies overlooked that lung ECs are exposed to diverse microenvironments in vivo (various hemodynamic forces and stimuli), which might result in their phenotypic and metabolic heterogeneity, though this has never been investigated. OBJECTIVES & EXPERIMENTAL APPROACH: In order to characterize, for the 1st time, the lung EC heterogeneity in PAH, identify EC subsets, and determine in an unbiased way the metabolic gene expression profiles of these EC subsets, I will use single-cell RNA-sequencing (scRNA-seq) on freshly isolated lung ECs from PAH patients and from an animal model of PH. As proof-of-concept, I will evaluate the effects of a new metabolic therapy on these EC subsets, in vivo, in comparison to a clinically-used, ameliorative but not curative, PAH therapy. This approach, already validated in the host lab, promises to lay the foundation of a new paradigm in PAH where lung ECs are phenotypically and metabolically heterogeneous. It will yield novel insights into PAH pathophysiology, identify specific EC subpopulations driving the vascular remodeling process as well as new potential metabolic targets. CAREER DEVELOPMENT: Combining my expertise on PAH (PhD thesis) together with state-of-the-art frontline technology (scRNA-seq) and innovative science (EC metabolism) (within the host lab) in a multi-disciplinary project and international research environment will ensure successful achievement of the project goals, enhance my scientific output and offer me a highly competitive basis for my future career in academia.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMPATHY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMPATHY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LiverMacRegenCircuit (2020)

Elucidating the role of macrophages in liver regeneration and tissue unit formation

Read More  

MY MITOCOMPLEX (2021)

Functional relevance of mitochondrial supercomplex assembly in myeloid cells

Read More  

SymCO (2020)

Asymptotic Symmetries: from Concepts to Observations

Read More